This country profile provides an overview of Burundi’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Priorities for progress in Burundi
- The status of the trachoma programme is dragging the index score for Burundi down, despite high coverage achieved for river blindness, bilharzia and intestinal worms.
- As a priority, Burundi is urged to implement the recommendations of the impact surveys for trachoma, by conducting one round of mass drug administration (MDA) in the districts of Gashoho and Gasorwe. Following which Burundi should carry out further impact surveys six months after the completion of the MDA.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Burundi does not require mass treatment for elephantiasis.
Treatment coverage remained the same at 0% in 2016 and 2017.
Treatment coverage decreased from 96% in 2016 to 94% in 2017.
Treatment coverage increased from 91% in 2016 to 100% in 2017.
Treatment coverage increased from 80% in 2016 to 81% in 2017.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Burundi.